Yüklüyor......
Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
BACKGROUND: Basiliximab and anti‐thymocyte globulin are widely used drugs for induction therapy after pediatric heart transplantation. The aim of this study was to determine whether any differences could be observed between basiliximab and anti‐thymocyte globulin, with respect to long‐term mortality...
Kaydedildi:
| Yayımlandı: | J Am Heart Assoc |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4859398/ https://ncbi.nlm.nih.gov/pubmed/26722127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.002790 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|